Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation
T. Yamamoto
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorY. Sawada
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorI. Katayama
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorK. Nishioka
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorT. Yamamoto
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorY. Sawada
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorI. Katayama
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this authorK. Nishioka
Department of Dermatology, Tokyo Medical and Dental University, School of Medicine, 1–5-45 Yushima, Bunkyo-ku, Tokyo 113–8519, Japan
Search for more papers by this author
References
- 1 Fleischmajer R, Perlish JS & Reeves IRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977; 20: 975 – 84.
- 2 Pope JE, Shum DT & Gottschalk R et al. Increased pigmentation in scleroderma. J Rheumatol 1996; 23: 1912 – 6.
- 3 Nishioka K, Kobayashi Y, Katayama I & Takijiri C. Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987; 123: 205 – 8.
- 4 Hawkins RA, Claman HN, Clark RAF & Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med 1985; 102: 182 – 6.
- 5 Yamamoto T, Katayama I & Nishioka K. Expression of stem cell factor in the lesional skin of systemic sclerosis. Dermatology 1998; 197: 109 – 14.
- 6 Kihira C, Mizutani H & Asahi K et al. Increased cutaneous immunoreactive stem cell factor expression and serum stem cell factor level in systemic scleroderma. J Dermatol Sci 1999; 20: 72 – 8.DOI: 10.1016/s0923-1811(98)00077-2
- 7 Costa JJ, Demetri GD & Harrist TJ et al. Recombinant human stem cell factor (c-kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996; 183: 2681 – 6.
- 8 Grichnik JM, Crawford J & Jimenez F et al. Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol 1995; 33: 577 – 83.
